| View |
|
DRP-11241
|
Cholecalciferol (Vitamin D3)
|
Vita-D-2000
|
2,000 IU
|
Film-Coated Tablet
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11227
|
Paracetamol
|
None
|
250 mg/5 mL
|
Suspension (Orange Flavor)
|
Analgesic/ Antipyretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial [OTC] (Correction)
|
27 June 2024
|
15 February 2027
|
| View |
|
DRP-11238
|
Ibuprofen + Paracetamol
|
Saphrefen-Plus
|
325 mg/200 mg
|
Capsule
|
Antipyretic-Analgesic/Non-Steroidal Anti-inflammatory
Drug (NSAID)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11240
|
Cholecalciferol
|
Ciferol -D
|
800 IU
|
Capsule
|
Vitamin
|
Drugmaker's Laboratories
|
Philippines
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11239
|
Domperidone
|
Dompesaph
|
1mg/mL
|
Oral Suspension (Tutti Frutti Flavor)
|
-
|
Azine Healthcare Pvt. Ltd.
|
India
|
-
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-2653-18
|
Buclizine Hydrochloride + Vitamin B Complex + Iron
|
Ziron Max
|
Formulation Each Capsule contains: Buclizine Hydrochloride-25mg Thiamine Mononitrate (Vitamin B1)- 10 mg Pyridoxine Hydrochloride (Vitamin B6)- 5 mg Cyanocobalamin (Vitamin B12)-0 mcg Iron (equivalent to 76.06 mg Ferrous Fumarate)
-25 mg
|
Capsule
|
Vitamins And Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (E-AR)
|
21 February 2024
|
11 March 2029
|
| View |
|
DRP-11109
|
Cetirizine hydrochloride
|
Dialix
|
2.5 mg/ mL
|
Syrup (Oral Drops) Banana flavor
|
Antihistamine (Piperazine Derivative)
|
Diamond Laboratories Inc.
|
Philippines
|
Initial
|
17 February 2022
|
17 February 2027
|
| View |
DR-XY47732_PIL_01.pdf
|
DR-XY47732
|
Ascorbic Acid + Zinc
|
Zorb8 Forte
|
890mg (equivalent to 1000mg Sodium Ascorbate) / 25 mg (equivalent to 69mg Zinc Sulfate Monohydrate)
|
Tablet
|
Vitamin/Mineral
|
Compact Pharmaceuticals, Corp.
|
Philippines
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DR-XY47728
|
Cholecalciferol (Vitamin D3)
|
None
|
2000 IU
|
Softgel Capsule
|
Vitamin
|
Phil Inter Pharma Co., Ltd. (Plant 1)
|
Vietnam
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
HRP-493
|
Paracetamol
|
Rapamol 120
|
120 mg/5 mL
|
Oral Suspension
|
Analgesic / Antipyretic
|
Rhydburg Pharmaceuticals Limited
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DR-XY47731
|
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
|
Kremil-S Cool Relief
|
356 mg/466 mg/20 mg per 20 mL
|
Suspension
(Menthol Flavor)
|
Antacid/Antiflatulent
|
United International Pharma Co., Ltd
|
Vietnam
|
Initial
|
17 February 2022
|
17 February 2027
|
| View |
|
DRP-11186
|
Atracurium (As Besilate)
|
Relaxium-AB
|
10 mg/mL (25 mg/ 2.5 mL)
|
Solution for Injection (I.V.)
|
Muscle Relaxant (Quaternary Ammonium Compound)
|
Gland Pharma Limited
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11176
|
Cefoperazone (as sodium) + Sulbactam (as sodium)
|
Cefobact
|
1 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin-Beta-Lactamase Inhibitor Combination)
|
Zeiss Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DR-XY47733
|
Famciclovir
|
Herpex Newgen
|
250 mg
|
Film-Coated Tablet
|
Antiviral (Nucleoside/Nucleotide)
|
Korea United Pharm. Inc.
|
Korea
|
Monitored Release
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11237
|
Epirubicin
|
Epicord 10
|
2mg/mL (10mg/5mL)
|
Concentrate Solution for
Injection (IV/Intravesical)
|
Antineoplastic
|
Intas Pharmaceuticals Limited
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11208
|
Metronidazole
|
None
|
500 mg
|
Film-Coated Tablet
|
Antiprotozoal/Antibacterial (Nitroimidazole derivative)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11210
|
Irbesartan
|
Irbis H 75
|
75mg
|
Tablet
|
-
|
Hetero Labs Limited (Unit V and Unit V-A)
|
India
|
-
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11212
|
Irbesartan
|
Irbis H 300
|
300mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Hetero Labs Limited (Unit V and Unit V-A)
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11211
|
Irbesartan
|
Irbis H 150
|
150mg
|
Tablet
|
-
|
Hetero Labs Limited (Unit V and Unit V-A)
|
India
|
-
|
16 February 2022
|
16 February 2027
|
| View |
|
DR-XY47729
|
Pancreatin
|
Enzystal P
|
116 mg
|
Enteric-Coated Tablet
|
Digestive Enzyme
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial (Correction)
|
01 April 2022
|
15 February 2027
|